University of Alabama at Birmigham, Women and Infants' Center
Birmingham, Alabama, 35233, United States
NCT Number: NCT03504670
Artificial rupture of membranes (amniotomy) is a commonly used technique to safely induce and augment labor. It has been shown to reduce the duration of spontaneous and induced labor in term patients (≥37 weeks' gestation). The utility of amniotomy in preterm patients (<37 weeks' gestation) undergoing medically-indicated induction of labor is unknown. However, it remains a commonly used strategy. We will conduct a trial comparing early amniotomy versus late amniotomy during medically-indicated induction of labor between 23.0 and 35.6 weeks gestation. Women will be randomized to early or late amniotomy after the obstetrician has decided to induce labor for a medical indication. We hypothesize that more women in the early amniotomy group will require cesarean delivery, and the duration of labor will increase in the early amniotomy group.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Birmingham, Alabama, 35233, United States
The rate of preterm birth in the United States is nearly 10%. Up to one-third of these births are the result of a medically-indicated delivery. While induction of labor in women at term gestation has been extensively studied, the same is not true for preterm gestations. Consequently, the same methods of labor induction are used in term and preterm gestations, although preterm gestations may have different responses to induction agents compared to term gestations.
At our institution, a standard induction of labor - for term or preterm women - is performed using a cervical Foley catheter or misoprostol for cervical ripening with the addition of intravenous oxytocin for labor augmentation. As membranes do not typically spontaneously rupture during the induction process, amniotomy is commonly utilized by providers to help augment labor. Amniotomy releases prostaglandin-rich amniotic fluid. These prostaglandins are important mediators of uterine contractility and ultimately active labor. It has been shown to reduce the duration of spontaneous and induced labor in term patients.
The timing of amniotomy is left up to the discretion of the treating providers, as there are no randomized controlled trials to support early versus late amniotomy at preterm gestations. However, a retrospective cohort of nulliparous and multiparous women at our institution undergoing induction at 23-34 weeks, and evaluating early amniotomy at <4cm cervical dilation versus late amniotomy at ≥4cm dilation, showed an increased risk of cesarean delivery and increased time from start of induction to delivery for early amniotomy, although only the cesarean delivery outcome was significant after adjusting for confounders.
We will conduct an intention-to-treat randomized controlled trial comparing early amniotomy versus late amniotomy during medically-indicated induction of labor between 23.0 and 35.6 weeks gestation. Women will be randomized to early or late amniotomy after the attending obstetrician has decided to induce labor for a medical indication. Early amniotomy will be performed prior to 4cm cervical dilation being reached. Late amniotomy will be performed at greater than or equal to 4cm cervical dilation.
The purpose of this study is to determine whether timing of amniotomy during medically-indicated preterm induction of labor affects labor outcomes. We will specifically be looking at risk of cesarean delivery, duration of labor, maternal morbidity, and neonatal morbidity. We hypothesize that more women in the early amniotomy group will require cesarean delivery and that the duration of labor will increase in the early amniotomy group.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This intervention involves using an amniotomy hook to rupture the membranes during a sterile vaginal exam. This intervention will be performed prior to the cervix being dilated 4cm.
This intervention involves using an amniotomy hook to rupture the membranes during a sterile vaginal exam. This intervention will be performed once the cervix is at least 4cm dilated.
Time frame: Duration is dependent upon the length of labor. The maximum time frame would be anticipated to be 120 hours from start of the induction.
Proportion of women requiring cesarean delivery
Time frame: Duration is dependent upon the length of labor. The maximum time frame would be anticipated to be 120 hours from start of the induction.
Time (hours) from the start of induction (initiation of first cervical ripening agent) to delivery (vaginal or cesarean)
Time frame: Duration is dependent upon the length of labor. The maximum time frame would be anticipated to be 120 hours from start of the induction.
Time (hours) from the start of induction (initiation of first cervical ripening agent) to vaginal delivery only
Time frame: Measured from start of induction of labor up to 42 days following delivery
Composed of seven outcomes:
Time frame: Measured up to 28 days of life for the newborn
Composed of five outcomes:
University of Alabama at Birmingham
Other
Acronym: PITA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06403059
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Banī Suwayf, Egypt
View Trial DetailsNCT06164080
Antenatal Corticosteroid, Perinatal Problems
Bursa, Turkey (Türkiye)
View Trial DetailsNCT03819933
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Boston, Massachusetts, United States
View Trial DetailsNCT06421506
Lung Diseases, Preterm Pregnancy
View Trial Details